Nexalin Technology (NXL) Net Cash Flow (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Net Cash Flow of $553112.0 in Q1 2026, up 754.78% quarter-over-quarter from $64708.0 in Q4 2025, and up 1063.37% on a YoY basis from $47544.0 in Q1 2025.
Nexalin Technology (NXL) Net Cash Flow (2021 - 2026) Analysis & Trends
Nexalin Technology's Net Cash Flow history runs 6 years deep, the most recent figure standing at $553112.0 for Q1 2026.
- In Q1 2026, Net Cash Flow rose 1063.37% year-over-year to $553112.0; the TTM figure through Mar 2026 stood at -$4.1 million (up 8.56% YoY), while the FY2025 annual figure was $80298.0, up 1497.7% from the prior year.
- Net Cash Flow was $553112.0 for Q1 2026 at Nexalin Technology, up from $64708.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $7.6 million in Q3 2022 to a low of -$5.3 million in Q3 2024.
- Historically, Net Cash Flow has averaged -$107152.0 across 5 years, with a median of $56761.0 in 2023.
- The sharpest annual moves came in 2024 and 2026: Net Cash Flow tumbled 4174.46% in 2024, then soared 1063.37% in 2026.
- A 5-year view of Net Cash Flow shows it stood at -$906457.0 in 2022, then soared by 124.14% to $218834.0 in 2023, then jumped by 125.31% to $493064.0 in 2024, then plunged by 86.88% to $64708.0 in 2025, then surged by 754.78% to $553112.0 in 2026.
- The last three Net Cash Flow figures came in at $553112.0 (Q1 2026), $64708.0 (Q4 2025), and $158755.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -159.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -282.15 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 202.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 20.30 Mn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | 553,112.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 553,112.00 |
| Mar 31, 2026 | 553,112.00 |
| Dec 31, 2025 | 64,708.00 |
| Dec 31, 2025 | 64,708.00 |
| Sep 30, 2025 | 158,755.00 |
| Sep 30, 2025 | 158,755.00 |
| Jun 30, 2025 | -4.84 Mn |
| Jun 30, 2025 | -4.84 Mn |
| Mar 31, 2025 | 47,544.00 |
| Mar 31, 2025 | 47,544.00 |
| Dec 31, 2024 | 493,064.00 |
| Dec 31, 2024 | 493,064.00 |
| Sep 30, 2024 | -5.28 Mn |
| Sep 30, 2024 | -5.28 Mn |
| Jun 30, 2024 | 302,541.00 |
| Jun 30, 2024 | 302,541.00 |
| Mar 31, 2024 | -33,975.00 |
| Mar 31, 2024 | -33,975.00 |
| Dec 31, 2023 | 218,834.00 |
| Dec 31, 2023 | 218,834.00 |